Clinical Trials Directory

Trials / Completed

CompletedNCT05244395

Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy

Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy: Gait Assessment Scale for Duchenne Muscular Dystrophy, and Its Validity and Reliability

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Hacettepe University · Academic / Other
Sex
Male
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to develop a gait assessment instrument for Duchenne Muscular Dystrophy patients (DMD-GAS), and investigate its validity and reliability.The scale was developed considering the expert opinions which included 10 physiotherapists who had experience in the management of patients with DMD over the 2-round Delphi method, and the Content Validity Index (CVI) was calculated. The final version of the DMD-GAS that was agreed upon the experts consisted of 10 items, and each item scored between 0 and 2. The intra-rater reliability was established by the video analysis of children with a 1-month interval and inter-rater reliability was determined by the scores of 3 physiotherapists. The criterion validity was determined by investigating the relationship between the total score of the DMD-GAS and Motor Function Measure (MFM), 6 Minute Walk Test (6MWT), and the data obtained from GAITRite system.

Conditions

Interventions

TypeNameDescription
OTHERDuchenne Muscular Dystrophy Gait Assessment Scalea special gait assessment scale for Duchenne Muscular Dystrophy patients

Timeline

Start date
2020-02-10
Primary completion
2021-11-30
Completion
2022-02-10
First posted
2022-02-17
Last updated
2022-03-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05244395. Inclusion in this directory is not an endorsement.